EVALUATION OF ANTICANCER ACTIVITY OF CUCUMIS CALLOSUS AGAINST EHRLICH'S ASCITES CARCINOMA BEARING MICE
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i10.27439Keywords:
Cucumis callosus, Anticancer, Ehrlich Ascites Carcinoma cell linesAbstract
Objective: Our previous research isolated Cucurbitacin B (CuB) and ebenone leucopentaacetate (ELP) from methanolic fruit extract of Cucumis callosus (MFCC). The fruits of C. callosus (Rottl.) Cogn. (Family: Cucurbitaceae) plant have been traditionally used for antioxidant, anti-inflammatory, and antidiabetic actions. The objective of this research was to evaluate in vitro and in vivo anticancer effect of MFCC on Ehrlich Ascites Carcinoma (EAC) cell lines.
Methods: In vitro anticancer assay of MFCC and standard drug, 5-fluorouracil (5-FU) was evaluated using Trypan blue and 3-(4, 5-dimethylthiazol-yl)-2, 5-diphenyl tetrazolium bromide methods. In vivo anticancer activity of MFCC and 5-FU was also performed after 24h of EAC cells (2×106cells/ mouse) inoculation based on toxicity study for 9 consecutive days. The activity of the extract was assessed by the study of tumor volume, tumor weight, viable and non-viable cell count, hematological parameters, and biochemical estimations.
Results: The MFCC showed the direct antitumor effect on EAC cells in a dose-dependent manner with an IG50 value of 0.61 mg/ml. Furthermore, MFCC (350 mg/kg) exhibited significant (p<0.01) decrease in tumor volume, tumor weight, and viable cell count of EAC-treated mice. Hematological profile, biochemical estimation assay significantly (p<0.01) reverted to normal level in MFCC, and 5-FU treated mice.
Conclusion: The anticancer activity of fruits of C callosus is may be either due to the presence of CuB or/and ELP as phytoconstituent and the activity is comparable to standard drug 5-FU.
Downloads
References
Abdullaev FI, Luna RR, Roitenburd BV, Espinosa AJ. The pattern of childhood cancer mortality in Mexico. Arch Med Res 2000;31:526-31.
Hussain MA, Pati S, Swain S, Prusty M, Kadam S, Nayak S, et al. Pattern and trends of cancer in Odisha, India: A retrospective study. Asian Pac J Cancer Prev 2012;13:6333-6.
Abdullaev FI. In: Plant-derived Agents Against Cancer, Gupta SK, editors. Pharmacology and Therapeutics in the New Millennium. New Delhi: Narosa Publishing House; 2001. p. 345-54.
Patwardhan B, Vaidya AD, Chorghade M. Ayurveda and natural products drug discovery. Curr Sci 2004;86:6.
Diwanay S, Gautam M, Patwardhan B. Cytoprotection and immunomodulation in cancer therapy. Curr Med Chem Anticancer Agents 2004;4:479-90.
Tripathy KD. Anticancer drugs. Essential Medical Pharmacology. 6th ed. New Delhi: Jaypee Brother’s Medical Publishers (P) Ltd.; 2007. p. 820.
Ramos AA, Prata-Sena M, Castro-Carvalho B, Dethoup T, Buttachon S, Kijjoa A, et al. Potential of four marine-derived fungi extracts as ant proliferative and cell death-inducing agents in seven human cancer cell lines. Asian Pac J of Trop Med 2015;8:798-806.
Bhattaram VA, Graefe U, Kohler C, Veit M, Derendorf H. Pharmacokinetic and bioavailability of herbal medicinal products. Phytomedicine 2002;9:1-33.
Hung HC, Joshipura KJ, Jiang R, Hu FB, Hunter D, Smith-Warner SA, et al. Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 2004;96:1577-84.
Rathore M. Nutrient content of important fruit trees from arid zone of Rajasthan. J Hortic For 2009;1:103-8.
Raut M. Glimpses of Nature Series (No. 4) our Monsoon Plants, Bombay Natural History Society. Bombay, India; 1959.
Trivedi PC. Medicinal plants: Traditional knowledge. In: Sharma UK, Gogoi J, editors. Ethno-Medico-Botany of some Sacred Plants of Dhemaji District of Assam. New Delhi: IK International Pvt. Ltd.; 2006. p. 102.
Haldar PK, Kar B, Bala A, Bhattacharya S, Mazumder UK. Antitumor activity of Sansevieria roxburghiana rhizome against Ehrlich ascites carcinoma in mice. Pharm Biol 2010;48:1337-43.
Islam K, Ali SM, Jesmin M, Khanam JA. In vivo teratogenic effect of the mixture using the Zebrafish embryo developmental assay. Cancer Biol Med 2012;9:242-7.
Panda SP, Sarangi AK, Panigrahy UP. Isolation of cucurbitacin-B from Cucumis callosus and its hypoglycemic effect in isolated rat enterocytes. Int J Pharm Pharm Sci 2018;10:123-9.
Kausar H, Munagala R, Bansal SS, Aqil F, Vadhanam MV, Gupta RC, et al. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: Identification of intracellular thiols as critical targets. Cancer Lett 2013;332:35-45.
Guo J, Wu G, Bao J, Hao W, Lu J, Chen X, et al. Cucurbitacin B induced ATM-mediated DNA damage causes G2/M cell cycle arrest in a ROS-dependent manner. PLoS One 2014;9:e88140.
Panda SP, Haldar PK, Bera S, Adhikary S, Kandar CC. Antidiabetic and antioxidant activity of Swietenia mahagoni in streptozotocin-induced diabetic rats. Pharm Biol 2010;48:974-9.
Bala A, Kara B, Haldar P, Mazumder U, Bera S. Evaluation of anticancer activity of Cleome gynandra on Ehrlich’s ascites carcinoma treated mice. J Ethnopharmacol 2010;129:131-4.
Mossman T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
Panda SP, Chakraborty M, Majumder P, Mazumder S, Das S, Haldar PK. The antidiabetic, antioxidant and anti-hyperlipidemic activity of Cucumis callosus in streptozotocin-induced diabetic rats. Int J Pharm Sci Res 2016;7:1978-84.
Prasad SB, Giri A. Antitumor effect of cisplatin against murine ascites dalton’s lymphoma. Indian J Exp Biol 1994;32:155-62.
Arias JL. Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems. Molecules 2008;13:2340 69.
Miura K, Kinouchi M, Ishida K, Fujibuchi W, Naitoh T, Ogawa H, et al 5-FU metabolism in cancer and orally-administrable 5-FU drugs. Cancers (Basel) 2010;2:1717-30.
Rajeshwar Y, Gupta M, Mazumder UK. Antitumor activity and in vivo antioxidant status of Mucuna pruriens (Fabaceae) seeds against Ehrlich ascites carcinoma in Swiss albino mice. Iranian J Pharmacol Ther 2005;4:46.
Chen JC, Chiu MH, Nie RL, Cordell GA, Qiu SX. Cucurbitacins and cucurbitane glycosides: Structures and biological activities. Nat Prod Rep 2005;22:386-99.
Militao GC, Dantas IN, Ferreira PM, Alves AP, Chaves DC, Monte FJ, et al. In vitro and in vivo anticancer properties of cucurbitacin isolated from Cayaponia racemose. Pharma Biol 2012;50:1479-87.
Duangmano S, Sae-Lim P, Suksamrarn A, Domann FE, Patmasiriwat P. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation. BMC Complement Altern Med 2012;12:185.
Thoennissen NH, Iwanski GB, Doan NB, Okamoto R, Lin P, Abbassi S, et al. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates cytotoxic effects of gemcitabine on pancreatic cancer cells. Cancer Res 2009;69:5876-84.
Brantley EC, Benveniste EN. STAT-3: A molecular hub for signaling pathways in gliomas. Mol Cancer Res 2008;6:5.
Mukherjee C, Paul S, Kundu R. Comparative evaluation of ant proliferative activity of Solanum nigrum methanolic and aqueous extract on HELA, SIHA and C33A cells. Int J Pharm Pharm Sci 2015;7:320-4.
Kumar Y, Periyasamy L. GC-MS analysis and in-vitro cytotoxic studies of Bixa orellana seed extract against cancer cell line. Int J Pharm Pharm Sci 2016;8:408-13.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.